Borodovsky, Alexandra <br/><br/>
5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft.  [electronic resource] 

 -  Oncotarget  Oct 2013 
 - 1737-47 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.1408  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antimetabolites, Antineoplastic--pharmacology<br/>Azacitidine--pharmacology<br/>Brain Neoplasms--drug therapy<br/>Cell Differentiation--drug effects<br/>Cell Growth Processes--drug effects<br/>Cell Line, Tumor<br/>DNA Methylation--drug effects<br/>Female<br/>Glioma--drug therapy<br/>Humans<br/>Immunohistochemistry<br/>Isocitrate Dehydrogenase--genetics<br/>Male<br/>Mice<br/>Mice, Nude<br/>Mutation<br/>Xenograft Model Antitumor Assays